Stock screener

ALNY

Conviction 5HealthcareScan · Fri, Jun 26, 2026
ALNY$291.68-0.51%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
5
Vol MA14 1.34M
Mar 27Apr 15May 4May 20Jun 9Jun 26
ALNYLAM PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.alnylam.com
Price291.68
Change-0.51%
Gap+1.32%
Rel volume1.23×
Avg volume1.31M
Avg $ vol382.13M
SMA 20291.02
SMA 50296.64
SMA 200370.21
Price vs 50-1.67%
Price vs 200-21.21%
MA stackbearish
50/200 cross
Supertrenddown · 308.40
RSI (14)49
MACD hist0.97
MACD crossbull · 2d
Stoch %K / %D61 / 59
ADX (14)17
+DI / −DI23 / 19
RSI divergence
MACD divergence
ATR %+3.52%
ADR %3.48%
52w high491.22
52w low278.09
From 52w high-40.62%
Above 52w low+4.89%
New 52w highNo
SqueezeOn · 1d
Bollinger width9.52%
%B0.52
Donchian pos49.63%
Donchian high310.53
Donchian low273.11
AVWAP (52w high)355.99
vs AVWAP high-18.06%
AVWAP (52w low)287.98
vs AVWAP low+1.28%
OBV trendDown
Chaikin MF (20)-0.12
Today vs 20d1.23×
Avg vol (14d)1.34M
Avg vol (20d)1.31M
Avg $ vol (20d)382.13M
Market cap
RS 3m (vs SPY)-22.61%
RS 6m (vs SPY)-35.32%
RS line new highNo
Trend template0/8
Technical rank23.6
1 week+4.89%
1 month-1.34%
3 months-11.12%
6 months-26.84%
1 year-9.40%
YTD-27.11%
P/E123.95
P/B49.28
P/S10.47
P/FCF83.57
EPS2.33
Div yield
ROE39.76%
ROA6.32%
Debt/Eq0.86
Current2.76
EV/EBITDA73.62
Gross margin
Net margin8.45%
Rev growth65.19%
EPS growth212.79%
Price target456.07
Target upside55.53%
Analyst ratingBuy
Institutional109.13%
Ent. value37.91B
Revenue1.25B
Net income251.08M
Gross profit
Free cash flow465.38M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out133.51M
Employees2.5K
ListedFri, May 28, 2004
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction5 / 100
Pattern quality
Tech rank23.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance308.28
Support278.11
Days since event
Candle confirm
News sentiment

Financials as of Tue, Sep 30, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALNY · 1 recent

All disclosures →
MemberSideAmount
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in ALNY · 2 buys · 6 sells

InsiderSideShares
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell495
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Other
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell17
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell1.18K
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Exercise3.83K
PYOTT DAVID E I
Director · Stock Option (Right to Buy) · 2026-06-01
Exercise3.83K
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell1.22K
Cravatt Benjamin
Director · Stock Option (Right to Buy) · 2026-06-01
Grant4.39K
PYOTT DAVID E I
Director · Common Stock · 2026-06-01
Sell921
Sigal Charles Elliott
Director · Common Stock · 2026-05-20
Other

SEC filings

EDGAR filings in ALNY · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.